AYALA PHARMACEUTICALS INC
ADXS Real Time Price USDRecent trades of ADXS by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ADXS's directors and management
Government lobbying spending instances
-
$80,000 Jan 21, 2018 Issue: Health Issues
-
$80,000 Oct 19, 2017 Issue: Health Issues
-
$70,000 Jul 11, 2017 Issue: Health Issues
-
$50,000 Apr 19, 2017 Issue: Health Issues
-
$50,000 Jan 23, 2017 Issue: Health Issues
-
$30,000 Jan 15, 2016 Issue: Health Issues
-
$30,000 Oct 19, 2015 Issue: Health Issues
-
$10,000 Apr 18, 2011 Issue: None
-
$10,000 Jan 19, 2011 Issue: Medical/Disease Research/Clinical Labs
-
$10,000 Oct 18, 2010 Issue: Budget/Appropriations
-
$10,000 Jul 19, 2010 Issue: Budget/Appropriations
-
$10,000 Apr 16, 2010 Issue: Budget/Appropriations
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ADXS in WallStreetBets Daily Discussion
Recent insights relating to ADXS
Recent picks made for ADXS stock on CNBC
ETFs with the largest estimated holdings in ADXS
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ADXS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.